CONNECT WITH US
Gaming

Gaming

Poison Ivy Show in Early Development with Penguin Showrunner in Talks to Produce

IGN logo

Published on

Add as a preferred source on Google
Poison Ivy Show in Early Development with Penguin Showrunner in Talks to Produce

Deadline has confirmed that DC Comics’ Poison Ivy is in the early stages of getting her own live-action TV show, and one of the minds that brought us the critically acclaimed Penguin series is in discussions to produce it.

However, the outlet’s sources state that this show won’t be part of Matt Reeves’ Batman universe, so don’t get your hopes up for the chance of seeing Colin Farrell’s Penguin or Battinson sharing the screen with Dr. Isley.

Lauren LeFranc, showrunner and executive producer on HBO’s The Penguin series, is currently in talks to produce the Poison Ivy show. If it gets picked up, it’ll also go to HBO for streaming, but it’s still very early days for the project.

Right now, there are no writers attached to the series, and no cast has been revealed, either. It’s anyone’s guess as to who will get the leading role (Uma Thurman is a hard act to follow), but there’s plenty of freedom to be had, given that Poison Ivy is a character that hasn’t yet been represented in newer DC projects.

Thus far, she hasn’t shown up in James Gunn’s DC cinematic universe, and there’s been no word on the character’s involvement in the next Batman film . It’s worth noting that Scarlett Johansson is confirmed as part of the movie’s cast, sparking no end of fan theories as to who she’ll be portraying. While rumors suggest she's playing Harvey Dent's wife, Gilda Dent, many fan theories are hoping against hope that she'll be Poison Ivy.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.